College ranks #16 overall, #9 among public institutions
COLUMBUS, Ohio – The Ohio State University College of Nursing continues to rank in the top 10 public colleges/schools of nursing throughout the country for research funding support from the National Institutes of Health (NIH). The college ranked #16 overall out of 89 institutions and #9 among public universities. According to the Blue Ridge Institute for Medical Research, the College of Nursing earned nearly $5 million in primary NIH research funding in 2022. Overall, the college has totaled an institutional high of more than $14M in external grant funds to support research and training in FY2022.
Our College of Nursing researchers continue to tackle challenges faced by Ohioans and people across the nation, said Karen Rose, PhD, RN, FGSA, FAAN, Vice Dean. “Finding solutions to promote optimal health and well-being and conquering health issues that face many of us is the hallmark of Ohio State College of Nursing research.”
College of Nursing research funded by the NIH in 2022:
Residential treatment for adolescents through behavioral parent training
Kayla Herbell, PhD, RN and Co-Investigators Susie Breitenstein, PhD, RN, FNAP, FAAN, Bernadette Melnyk, PhD, APRN-CNP, FAANP, FNAP, FAAN and Alai Tan, PhD received a three-year $708,750 R34 grant from the NIH/National Institute of Mental Health (NIMH). The study, “Optimizing residential treatment gains for adolescents through tailored behavioral parent training,” will use an established web-based parent training program called Parenting Wisely to help families with adolescents aged 11-17 transition from psychiatric residential treatment (RT) to the community. By providing parents with tailored education and support, parents will be equipped with the behavior management skill set to provide structure in the home and ultimately sustain RT treatment gains.
Improving sexual minority health among rural vs. urban populations
Ethan Morgan, PhD received a two-year $172,776 R03 grant funded by the NIH/National Institute on Drug Abuse (NIDA). The study, “Improving sexual minority health: differences in substance use, substance use treatment, and associated chronic diseases among Rural vs. Urban populations,” aims to further research on differences between populations in terms of use and success of substance abuse treatment programs. Rural environments suffer from a lack of treatment options and an increased burden of substance use disorders.
“The broad goals of this project are not only to reduce the burden of substance use on rural communities but to also identify and eliminate health disparities between urban and rural sexual minorities,” Morgan said about the project.
A promising start to NIH funding in FY2023:
Diabetes health disparities in African American populations
Jie Hu, PhD, RN, FAAN and Co-Investigators Lorraine C. Mion, PhD, RN, FAAN, Suzanne Bartle-Haring, PhD, Joshua J. Joseph, MD, MPH, FAHA and Carla K. Miller, PhD received a three-year $945,000 R01 grant funded by the NIH/National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) for the study titled, “A Family-Dyad-Focused Diabetes Self-Management Intervention for African American Adults with Type 2 Diabetes.” The study focuses on health disparities in diabetes that disproportionately affect the health of African American people by using a dyadic-centered approach that values African American culture of interdependence. It tests a diabetes self-management intervention with the goal of improving diabetes management for African American adults with type 2 diabetes.
Cognitive training for cancer-related cognitive impairment
Diane Von Ah, PhD, RN, FAAN and Co-Investigators Patricia Ganz, MD (MPI), Brenna McDonald, MBA, PsyD, ABPP-CN (MPI) and Hanna Bandos, PhD received a five-year $2,766,520 R01 grant funded by the NIH/National Cancer Institute (NCI) for the study titled, “Cognitive Training for Cancer-related Cognitive Impairment (CRCI): A Multi-Center Randomized Controlled Trial.” The study is the first national-scale test. It will use a computerized cognitive training program against a computerized active attention control program to improve self-reported and objective cognitive functioning in breast cancer survivors with cancer and cancer treatment-related cognitive impairment. It will be conducted in collaboration with the NCI’s National Community Oncology Research Program at their national clinical trials network sites. The results will be used to guide clinicians’ recommendations and treatment selections for managing breast cancer survivors with cancer and CRCI.
“We are so proud of the vibrant scientific community in our College of Nursing and the tremendous impact that College of Nursing researchers have on pressing problems in health promotion and disease prevention,” said Mary Beth Happ, PhD, RN, FGSA, FAAN, Senior Associate Dean for Research and Innovation. “Importantly, our researchers are working to understand and eliminate health disparities among persons in marginalized and underserved groups.”
